Drugs should be priced bad on Benefit to risk ratio and not just because it’s new
Filed under: cancer alternative medicine
from WordPress http://ift.tt/2i4QubN
via IFTTT
Drugs should be priced bad on Benefit to risk ratio and not just because it’s new
No comments:
Post a Comment